Diabetic Foot Ulcer Market: Omnigraft approval seen as catalyst for Integra, DFU market Jan. 11, 2016 By Amanda Pedersen A new FDA approval is expected to be an important catalyst for Integra Lifesciences Corp. (Plainsboro, N.J.) and represents a step in the right direction for the broader diabetic foot ulcer (DFU) market.Read More
Inside the Beltway: Hatch, Wyden urge CMS to redo PAMA reporting mandates Jan. 11, 2016 By Mark McCarty
Call Me Maybe: Cardiac variants fail to predict risk in prospective study Jan. 11, 2016 By Anette Breindl
TAVR provides fertile market for firm: Vivasure Medical picks up CE mark for percutaneous vascular closure device Jan. 11, 2016 By Omar Ford
Opponents say not a wise move: Indian government urged to rethink health care price caps Jan. 11, 2016 By Pearl Liu
RSS